Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years-Reference-Cited by-同舟云学术

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years

Published:2003-07 Issue:4 Volume:10 Page:337-344
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:Menopause

Author:

Jolly Elaine E.,Bjarnason Nina H.,Neven Patrick,Plouffe, Leo,Johnston, C. Conrad,Watts Steven D.,Arnaud Claude D.,Mason Timothy M.,Crans Gerald,Akers Robin,Draper Michael W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference28 articles.

1. Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical Trial

2. Long-term Effects of Raloxifene on Bone Mineral Density, Bone Turnover, and Serum Lipid Levels in Early Postmenopausal Women

3. Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

4. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

5. Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Sequence for Osteoporosis;Endocrine Practice;2024-05

2. Position Statement: Postmenopausal Osteoporosis Treatment Strategies in Korea;Journal of Bone Metabolism;2023-11-30

3. Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women;Scientific Reports;2022-05-03

4. Terapia ormonale sostitutiva e osteoporosi postmenopausale;L'Endocrinologo;2022-02

5. Osteoporosis: Epidemiology, Pathogenesis, Evaluation and Treatment;Open Journal of Orthopedics;2022